MIT -- In work that could lead to new drugs to target Alzheimer’s disease, MIT researchers and colleagues have shed light on one of the molecular mysteries surrounding this common form of dementia.
MIT -- In work that could lead to new drugs to target Alzheimer’s disease, MIT researchers and colleagues have shed light on one of the molecular mysteries surrounding this common form of dementia.
